DST saved economy NIS 70m.

Daylight savings time generated some NIS 70 million for the local economy through a combination of lower electricity consumption, increased worker productivity and a rise in sales, the Federation of Israeli Chambers of Commerce reported on Sunday.

By MATTHEW KRIEGER
September 10, 2007 07:51

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Daylight savings time generated some NIS 70 million for the local economy through a combination of lower electricity consumption, increased worker productivity and a rise in sales, the Federation of Israeli Chambers of Commerce reported on Sunday. The summer clock, which is set to end Sunday September 16 when the country switches its clocks back one hour, also added greatly to the quality of life of Israeli citizens, said Yechezkel Daskal, director general of the FICC, as it provided an additional hour of daylight to enjoy free-time with family and friends.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS